Inventor · disambiguated record
James A. Burke
Also filed as: BURKE JAMES · BURKE JAMES A · BURKE JAMES ALBERT · BURKE JAMES R
48 granted patents·40 pending applications·1,110 citations·filing 1989–2023
99Inventor score
Top patents by PatentIndex Score
88 records- 0198US7931909B2Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance ratesALLERGAN INC·Filed 2006·Granted Apr 26, 2011·64 cites·9 claims
- 0297US8647659B2Intracameral sustained release therapeutic agent implantsROBINSON MICHAEL R·Filed 2011·Granted Feb 11, 2014·46 cites·5 claims
- 0397US8293210B2Sustained release intraocular implants and methods for preventing retinal dysfunctionHUANG GLENN T·Filed 2007·Granted Oct 23, 2012·34 cites·6 claims
- 0497US6329369B1Methods of treating pain and other conditionsALLERGAN SALES INC·Filed 2000·Granted Dec 11, 2001·83 cites·17 claims
- 0596US8821870B2Method for treating atrophic age related macular degenerationROBINSON MICHAEL R·Filed 2008·Granted Sep 2, 2014·38 cites·4 claims
- 0694US10278919B2Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2016·Granted May 7, 2019·10 cites·13 claims
- 0794US6841684B2Imidiazoles having reduced side effectsALLERGAN INC·Filed 2001·Granted Jan 11, 2005·72 cites·18 claims
- 0893US9504696B2Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2015·Granted Nov 29, 2016·8 cites·14 claims
- 0993US9061065B2Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2013·Granted Jun 23, 2015·15 cites·6 claims
- 1092US10653621B2Biodegradable drug delivery systems for the sustained release of proteinsALLERGAN INC·Filed 2013·Granted May 19, 2020·9 cites·4 claims
- 1191US8425929B2Sustained release intraocular implants and methods for preventing retinal dysfunctionHUANG GLENN T·Filed 2004·Granted Apr 23, 2013·25 cites·4 claims
- 1290US8293741B2Intraocular implants and methods for improving visionBURKE JAMES A·Filed 2005·Granted Oct 23, 2012·15 cites·3 claims
- 1390US8231892B2Biodegradable drug delivery systemLYONS ROBERT T·Filed 2007·Granted Jul 31, 2012·6 cites·5 claims
- 1489US8956655B2Biodegradable drug delivery systemLYONS ROBERT T·Filed 2012·Granted Feb 17, 2015·10 cites·19 claims
- 1589US5756503AMethods for using (2-imidazolin-2-ylamino) Quinoxaline derivativesALLERGAN INC·Filed 1996·Granted May 26, 1998·55 cites·17 claims
- 1688US5703077AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1996·Granted Dec 30, 1997·49 cites·19 claims
- 1787US5561132AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1995·Granted Oct 1, 1996·47 cites·17 claims
- 1887US2024148643A1Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2023·Application pending·0 cites
- 1986US9161938B2Sustained release intraocular implants and methods for treating ocular vasculopathiesHUANG GLENN T·Filed 2008·Granted Oct 20, 2015·6 cites·6 claims
- 2085US5215991ACombination of selective alpha-adrenergic agonists and Na+ /H+ exALLERGAN INC·Filed 1990·Granted Jun 1, 1993·73 cites·12 claims
- 2184US8506986B2Sustained release intraocular implants and methods for treating ocular vasculopathiesHUANG GLENN T·Filed 2008·Granted Aug 13, 2013·4 cites·1 claims
- 2282US5773440AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1997·Granted Jun 30, 1998·32 cites·18 claims
- 2382US5552403AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1994·Granted Sep 3, 1996·28 cites·17 claims
- 2481US10363214B2Method for treating atrophic age related macular degenerationALLERGAN INC·Filed 2014·Granted Jul 30, 2019·3 cites·14 claims
- 2581US8529927B2Alpha-2 agonist polymeric drug delivery systemsCHANG JAMES N·Filed 2006·Granted Sep 10, 2013·1 cites·4 claims
- 2681US5281591ACombinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressureALLERGAN INC·Filed 1992·Granted Jan 25, 1994·62 cites·4 claims
- 2780US6323204B1Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1998·Granted Nov 27, 2001·46 cites·17 claims
- 2879US2020121593A1Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2019·Application pending·0 cites
- 2976US11096958B2Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicityALLERGAN INC·Filed 2019·Granted Aug 24, 2021·1 cites·12 claims
- 3076US5587376AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1995·Granted Dec 24, 1996·24 cites·18 claims
- 3175US10201641B2Sustained release intraocular implants and methods for treating ocular vasculopathiesALLERGAN INC·Filed 2015·Granted Feb 12, 2019·1 cites·6 claims
- 3275US5714486AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1996·Granted Feb 3, 1998·22 cites·18 claims
- 3375US2021169780A1Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2020·Application pending·0 cites
- 3473US9572859B2Compositions and methods for localized therapy of the eyeALLERGAN INC·Filed 2013·Granted Feb 21, 2017·1 cites·2 claims
- 3573US6706747B2Conformationally rigid bicyclic and adamantane derivatives useful as α2-adrenergic blocking agentsALLERGAN INC·Filed 2003·Granted Mar 16, 2004·4 cites·10 claims
- 3673US6319935B1Conformationally rigid bicyclic and adamantane derivatives useful as α2-adrenergic blocking agentsALLERGAN SALES INC·Filed 2000·Granted Nov 20, 2001·4 cites·10 claims
- 3770US5326763AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1993·Granted Jul 5, 1994·28 cites·16 claims
- 3870US5231096AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1992·Granted Jul 27, 1993·24 cites·17 claims
- 3970US2015174062A1Biodegradable drug delivery systemALLERGAN INC·Filed 2014·Application pending·0 cites
- 4069US6087361AAryl-imidazolines and aryl-imidazoles useful as α-2 adrenergic agonists without cardiovascular side effectsALLERGAN SALES INC·Filed 1997·Granted Jul 11, 2000·32 cites·7 claims
- 4169US5180721ACombinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressureALLERGAN INC·Filed 1991·Granted Jan 19, 1993·38 cites·4 claims
- 4269US2019254965A1Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2019·Application pending·0 cites
- 4368US6569884B2Conformationally rigid bicyclic and adamantane derivatives useful as α2-adrenergic blocking agentsALLERGAN INC·Filed 2001·Granted May 27, 2003·2 cites·12 claims
- 4467US5021410ACombinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressureALLERGAN INC·Filed 1989·Granted Jun 4, 1991·30 cites·10 claims
- 4567US2019167858A1Sustained release intraocular implants and methods for treating ocular vasculopathiesALLERGAN INC·Filed 2019·Application pending·0 cites
- 4666US8580292B2Sustained release intraocular implants and methods for treating ocular vasculopathiesHUANG GLENN T·Filed 2008·Granted Nov 12, 2013·0 cites·3 claims
- 4765US11738043B2Sodium chlorite compositions with enhanced antimicrobial efficacy and reduced toxicityALLERGAN INC·Filed 2021·Granted Aug 29, 2023·0 cites·13 claims
- 4864US5418234AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1994·Granted May 23, 1995·22 cites·19 claims
- 4964US5373010AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1994·Granted Dec 13, 1994·22 cites·19 claims
- 5064US2011251201A1Sustained release intraocular implants and methods for preventing retinal dysfunctionALLERGAN INC·Filed 2011·Application pending·0 cites
Showing the top 50 of 88 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James A. Burke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →